Nurix Therapeutics, Inc. NRIX Interest Income
Interest Income at other companies
Other financials
Where this comes from
Reported directly by Nurix Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestAndOtherIncome.
The official record: Nurix Therapeutics, Inc.’s 10-Q, filed April 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nurix Therapeutics, Inc.'s interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nurix Therapeutics, Inc.'s interest income?
- Nurix Therapeutics, Inc. (NRIX) reported interest income of $5.32M in Q4 2025.
- How has Nurix Therapeutics, Inc.'s interest income changed year-over-year?
- Nurix Therapeutics, Inc.'s interest income decreased by 18.3% year-over-year, from $6.51M to $5.32M.
- What is the long-term trend for Nurix Therapeutics, Inc.'s interest income?
- Over 4 years (2021 to 2025), Nurix Therapeutics, Inc.'s interest income has grown at a 127.3% compound annual growth rate (CAGR), from $823K to $21.97M.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.